Literature DB >> 33411038

Preoperative transarterial chemoembolization for laparoscopic liver resection in Child A cirrhotic patients with hepatocellular carcinoma.

Víctor Lopez-Lopez1, Roberto Brusadin1, Asunción López-Conesa1, Antonio Capel2, Álvaro Navarro-Barrios1, Valentín Cayuela1, Elena Lopez-Banet3, Alejandro Garzón-Arana4, Pascual Parrilla-Paricio1, Ricardo Robles-Campos5.   

Abstract

PURPOSE: Laparoscopic liver resection (LLR) for hepatocellular carcinoma (HCC) offers better short-term results than open surgery with similar long-term results although it is technically difficult due to the risk of bleeding.
METHODS: This study included patients with HCC in Child A cirrhosis who underwent TACE before LLR between 2009 and 2019. The primary endpoint was to analyze the intraoperative and early results of this technique. We also analyzed the long-term outcomes. Patients with and without clinically significant portal hypertension (CSPH) were compared.
RESULTS: A total of 44 cirrhotic patients with HCC were included (24 CSPH and 20 non-CSPH). The Pringle maneuver was used in two cases (4.5%), mean blood losses was 100 ml (range 50-200), and three patients (6.8%) required a blood transfusion. The degree of necrosis achieved was greater than 90% in 27 patients (61.4%). At 1, 3, and 5 years, overall survival was 97.7%, 81.5%, and 63.4%, respectively, and disease-free survival was 85.2%, 52.5%, and 34.5%, respectively. There were no statistically significant differences between non-CSPH and CSPH groups regarding intraoperative, early, and long-term outcomes.
CONCLUSION: In our experience, TACE could be beneficial to perform LLR in HCC Child-Pugh A patients with and without CSPH without serious complications and similar oncological outcomes.

Entities:  

Keywords:  Hepatocellular carcinoma; Laparoscopy; Liver resection; Transarterial chemoembolization

Year:  2021        PMID: 33411038     DOI: 10.1007/s00423-020-02056-x

Source DB:  PubMed          Journal:  Langenbecks Arch Surg        ISSN: 1435-2443            Impact factor:   3.445


  20 in total

1.  Laparoscopic versus open liver resection for hepatocellular carcinoma in posterosuperior segments.

Authors:  Le Xiao; Lun-jian Xiang; Jian-wei Li; Jian Chen; Yu-dong Fan; Shu-guo Zheng
Journal:  Surg Endosc       Date:  2015-04-22       Impact factor: 4.584

2.  Is it Time to Change the Standard Procedure for Hepatocellular Carcinoma from an Open to a Laparoscopic Approach?

Authors:  Isidoro Di Carlo; Adriana Toro
Journal:  J Am Coll Surg       Date:  2015-05       Impact factor: 6.113

3.  Long-term favorable surgical results of laparoscopic hepatic resection for hepatocellular carcinoma in patients with cirrhosis: a single-center experience over a 10-year period.

Authors:  Yo-ichi Yamashita; Tetsuo Ikeda; Takeshi Kurihara; Yoshihiro Yoshida; Kazuki Takeishi; Shinji Itoh; Norifumi Harimoto; Hirofumi Kawanaka; Ken Shirabe; Yoshihiko Maehara
Journal:  J Am Coll Surg       Date:  2014-09-08       Impact factor: 6.113

4.  Laparoscopic versus open major hepatectomy for hepatocellular carcinoma: a matched pair analysis.

Authors:  Shohei Komatsu; Raffaele Brustia; Claire Goumard; Fabiano Perdigao; Olivier Soubrane; Olivier Scatton
Journal:  Surg Endosc       Date:  2015-07-21       Impact factor: 4.584

5.  Prognosis of hepatocellular carcinoma: the BCLC staging classification.

Authors:  J M Llovet; C Brú; J Bruix
Journal:  Semin Liver Dis       Date:  1999       Impact factor: 6.115

6.  Laparoscopic vs. open liver resection for hepatocellular carcinoma of cirrhotic liver: a case-control study.

Authors:  Riccardo Memeo; Nicola de'Angelis; Philippe Compagnon; Chady Salloum; Daniel Cherqui; Alexis Laurent; Daniel Azoulay
Journal:  World J Surg       Date:  2014-11       Impact factor: 3.352

7.  Severity of cirrhosis should determine the operative modality for patients with early hepatocellular carcinoma and compensated liver function.

Authors:  Zhi-yong Huang; Bin-yong Liang; Min Xiong; Ke-shuai Dong; Zun-yi Zhang; Er-lei Zhang; Chang-hai Li; Xiao-ping Chen
Journal:  Surgery       Date:  2015-10-06       Impact factor: 3.982

8.  Laparoscopic liver resection of hepatocellular carcinoma located in unfavorable segments: a propensity score-matched analysis from the I Go MILS (Italian Group of Minimally Invasive Liver Surgery) Registry.

Authors:  Giovanni Battista Levi Sandri; Giuseppe Maria Ettorre; Luca Aldrighetti; Umberto Cillo; Raffaele Dalla Valle; Alfredo Guglielmi; Vincenzo Mazzaferro; Alessandro Ferrero; Fabrizio Di Benedetto; Salvatore Gruttadauria; Luciano De Carlis; Giovanni Vennarecci
Journal:  Surg Endosc       Date:  2018-09-10       Impact factor: 4.584

9.  Tumor response evaluation criteria for HCC (hepatocellular carcinoma) treated using TACE (transcatheter arterial chemoembolization): RECIST (response evaluation criteria in solid tumors) version 1.1 and mRECIST (modified RECIST): JIVROSG-0602.

Authors:  Yozo Sato; Hirokazu Watanabe; Miyuki Sone; Hiroaki Onaya; Noriaki Sakamoto; Keigo Osuga; Masahide Takahashi; Yasuaki Arai
Journal:  Ups J Med Sci       Date:  2012-11-20       Impact factor: 2.384

10.  Is there a standard for surgical therapy of hepatocellular carcinoma in healthy and cirrhotic liver? A comparison of eight guidelines.

Authors:  Giulia Manzini; Doris Henne-Bruns; Franz Porzsolt; Michael Kremer
Journal:  BMJ Open Gastroenterol       Date:  2017-03-24
View more
  2 in total

1.  New and effective method to develop primary hepatocytes from liver cancer patients.

Authors:  Jia-Yan Li; Li-Li Wang; Jing Fan; Du-Xian Liu; Jian-Bo Han; Yu-Feng Zhang; Dan-Dan Yin; Yong-Xiang Yi
Journal:  Exp Biol Med (Maywood)       Date:  2022-04-26

2.  Effect of Transarterial Chemoembolization Plus Percutaneous Ethanol Injection or Radiofrequency Ablation for Liver Tumors.

Authors:  Lei Chen; Weihua Zhang; Tao Sun; Yanqiao Ren; Bo Sun; Licheng Zhu; Huangxuan Zhao; Chuansheng Zheng
Journal:  J Hepatocell Carcinoma       Date:  2022-08-12
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.